These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9931161)

  • 1. State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity.
    Mark AL; Correia M; Morgan DA; Shaffer RA; Haynes WG
    Hypertension; 1999 Jan; 33(1 Pt 2):537-41. PubMed ID: 9931161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
    Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
    Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin and the central neural mechanisms of obesity hypertension.
    Rahmouni K; G Haynes W
    Drugs Today (Barc); 2002 Dec; 38(12):807-17. PubMed ID: 12582470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-associated hypertension: new insights into mechanisms.
    Rahmouni K; Correia ML; Haynes WG; Mark AL
    Hypertension; 2005 Jan; 45(1):9-14. PubMed ID: 15583075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obesity induced by abnormality in leptin receptor and melanocortin-4 receptor].
    Shintani M; Ogawa Y; Nakao K
    Nihon Rinsho; 2002 Feb; 60(2):404-9. PubMed ID: 11857934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocortin and leptin signaling systems: central regulation of catabolic energy balance.
    Fisher SL; Yagaloff KA; Burn P
    J Recept Signal Transduct Res; 1999; 19(1-4):203-16. PubMed ID: 10071759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
    Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
    Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway.
    do Carmo JM; da Silva AA; Dubinion J; Sessums PO; Ebaady SH; Wang Z; Hall JE
    IUBMB Life; 2013 Aug; 65(8):692-8. PubMed ID: 23847053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits.
    Barzel B; Lim K; Davern PJ; Burke SL; Armitage JA; Head GA
    J Hypertens; 2016 Mar; 34(3):464-73; discussion 473. PubMed ID: 26820476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity research. Tracing leptin's partners in regulating body weight.
    Gura T
    Science; 2000 Mar; 287(5459):1738-41. PubMed ID: 10755923
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropeptides responding to leptin.
    Wolf G
    Nutr Rev; 1997 Mar; 55(3):85-8. PubMed ID: 9170895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of Aberrant Blood Pressure and Sympathetic Regulation in Diet-Induced Obesity.
    Lim K; Barzel B; Burke SL; Armitage JA; Head GA
    Hypertension; 2016 Aug; 68(2):491-500. PubMed ID: 27296999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of leptin in obesity-related hypertension.
    Haynes WG
    Exp Physiol; 2005 Sep; 90(5):683-8. PubMed ID: 16105937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin Is Not Essential for Obesity-Associated Hypertension.
    von Schnurbein J; Manzoor J; Brandt S; Denzer F; Kohlsdorf K; Fischer-Posovszky P; Weißenberger M; Frank-Podlech S; Mahmood S; Wabitsch M
    Obes Facts; 2019; 12(4):460-475. PubMed ID: 31357197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity hypertension: role of leptin and sympathetic nervous system.
    Hall JE; Hildebrandt DA; Kuo J
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):103S-115S. PubMed ID: 11411745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
    Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension.
    da Silva AA; do Carmo JM; Wang Z; Hall JE
    Curr Hypertens Rep; 2019 Apr; 21(6):46. PubMed ID: 31028563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives on the origin of hypertension; the role of the hypothalamic melanocortin system.
    Samuelsson AM
    Exp Physiol; 2014 Sep; 99(9):1110-5. PubMed ID: 25210109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the pathogenesis of obesity-induced hypertension.
    Kotsis V; Nilsson P; Grassi G; Mancia G; Redon J; Luft F; Schmieder R; Engeli S; Stabouli S; Antza C; Pall D; Schlaich M; Jordan J;
    J Hypertens; 2015 Aug; 33(8):1499-508. PubMed ID: 26103132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the pathogeny of obesity: the physiology of leptin].
    Palacios García N; González Albarrán O; Varela Dacosta C
    Rev Clin Esp; 1997 May; 197(5):351-7. PubMed ID: 9280970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.